Composition
- Active ingredients
- ATAZANAVIR SULFATE 300MG; RITONAVIR 100MG; LAMIVUDINE 150MG; ZIDOVUDINE 300MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA206041.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Atazanavir Sulfate;Ritonavir;Lamivudine;Zidovudine
- Active substance
- atazanavir sulfate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Mylan Labs LTD
- Status
- Tentative approval
- FDA approval
- 4 Sept 2014
- Application
- NDA206041-001